Displaying drugs 226 - 250 of 367 in total
Enibomal
Experimental
Hexamethonium
A nicotinic cholinergic antagonist often referred to as the prototypical ganglionic blocker. It is poorly absorbed from the gastrointestinal tract and does not cross the blood-brain barrier. It has been used for a variety of therapeutic purposes including hypertension but, like the other ganglionic blockers, it has been replaced by...
Experimental
Matched Salts name: … Hexamethonium Bromide …
4-Bromo-2,5-dimethoxyphenethylamine
Experimental
Illicit
TRIAZOLOPYRIMIDINE
Experimental
CRA_9076
Experimental
1-(3-bromophenyl)-7-chloro-6-methoxy-3,4-dihydroisoquinoline
1-(3-bromophenyl)-7-chloro-6-methoxy-3,4-dihydroisoquinoline is a solid. This compound belongs to the isoquinolines and derivatives. These are aromatic polycyclic compounds containing an isoquinoline moiety, which consists of a benzene ring fused to a pyridine ring and forming benzo[c]pyridine. This medication is known to target mitogen-activated protein kinase 10.
Experimental
N-(3,5-dibromo-4-hydroxyphenyl)benzamide
Experimental
(5-BROMO-4-CHLORO-3-INDOLYL)-A-D-MANNOSE
Experimental
Epacadostat
Epacadostat has been used in trials studying the treatment of HL, Melanoma, Glioblastoma, Mucosal Melanoma, and Ovarian Carcinoma, among others.
Investigational
ATX-914
Axt914 is under investigation in clinical trial NCT00417261 (Safety, Tolerability, Pharmacodynamic and Pharmacokinetic Effects of Single and Multiple-Doses of ATF936 and AXT914 Administered Orally in Healthy Subjects.).
Investigational
4-Bromo-2,5-dimethoxyamphetamine
Experimental
Illicit
CRA-9334
Experimental
Displaying drugs 226 - 250 of 367 in total